Sylvie Hermouet and Mathias Vilaine (2011) “The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?”, Haematologica. Pavia, Italy, 96(11), pp. 1575-1579. doi: 10.3324/haematol.2011.055392.